[{"Assets_0_Q2_USD":22127000.0,"CommonStockSharesOutstanding_0_Q2_shares":22278090.0,"NetIncomeLoss_2_Q2_USD":-13623000.0,"NetIncomeLoss_1_Q2_USD":-6542000.0,"StockholdersEquity_0_Q2_USD":806000.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170810"}]